ArticlePharmaceuticals (Basel, Switzerland)2024

A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for Glioblastoma.

Ioannis Ntafoulis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.